Impact of the COVID-19 pandemic on the work of urological departments
- 作者: Kulchavenya E.1,2,3, Kholtobin D.1,2,3, Telina E.3
-
隶属关系:
- Novosibirsk Research Institute of Tuberculosis
- Novosibirsk State Medical University
- Avicenna Medical Center of the Mother and Child group of companies
- 期: 卷 12, 编号 1 (2022)
- 页面: 5-12
- 栏目: Original articles
- URL: https://journals.rcsi.science/uroved/article/view/97019
- DOI: https://doi.org/10.17816/uroved97019
- ID: 97019
如何引用文章
详细
BACKGROUND: The pandemic of a new coronavirus infection has had a significant impact on the work of the entire medical service, including urological departments.
AIM: to assess the impact of the COVID-19 pandemic on the work of urological departments in private and public medical institutions.
MATERIALS AND METHODS: We assessed the impact of the restrictions imposed by the pandemic on the work of the urology department of a private clinic (MC Avicenna, Novosibirsk) and the urogenital department of the Novosibirsk Research Institute of Tuberculosis for 2019 and 2020. We assessed the change in the range of surgical interventions, as well as the structure visits to the urologist.
RESULTS: The urogenital department of the Novosibirsk Research Institute of Tuberculosis in March 2020 was redesigned into an observational one. The Avicenna Medical Center also established the procedure for anti-epidemic measures, which made it possible not only not to reduce, but in a number of positions to increase the volume of surgical care provided.
CONCLUSION: Thus, thanks to anti-epidemic measures: separation of flows, introduction of mandatory testing of patients, early detection of patients and carriers among employees, mask regimen, opening of an observational department, single rooms, lack of contact between patients, short stays, it was possible to prevent an outbreak of infection among patients and staff. Both in the municipal and private urological clinics, well-organized work did not allow the negative impact of the pandemic to manifest itself.
作者简介
Ekaterina Kulchavenya
Novosibirsk Research Institute of Tuberculosis; Novosibirsk State Medical University; Avicenna Medical Center of the Mother and Child group of companies
Email: urotub@yandex.ru
ORCID iD: 0000-0001-8062-7775
SPIN 代码: 5244-4960
Scopus 作者 ID: 6505712683
https://www.researchgate.net/profile/Ekaterina_Kulchavenya
Dr. Sci. (Med.), Professor, Chief Researcher
俄罗斯联邦, 81A, Okhotskaya st., Novosibirsk, 630040; Novosibirsk; NovosibirskDenis Kholtobin
Novosibirsk Research Institute of Tuberculosis; Novosibirsk State Medical University; Avicenna Medical Center of the Mother and Child group of companies
Email: urology-avicenna@mail.ru
ORCID iD: 0000-0001-6645-6455
SPIN 代码: 5473-4282
Scopus 作者 ID: 54889009300
Cand. Sci. (Med.), Senior Research Fellow
俄罗斯联邦, 81A, Okhotskaya st., Novosibirsk, 630040; Novosibirsk; NovosibirskElena Telina
Avicenna Medical Center of the Mother and Child group of companies
编辑信件的主要联系方式.
Email: avicenna.info@mcclinics.ru
General Director of the Avicenna Medical Center of the Mother and Child group of companies
俄罗斯联邦, 81A, Okhotskaya st., Novosibirsk, 630040参考
- koronavirustoday.ru [Internet]. Coronavirus in World. Available from: https://koronavirustoday.ru/news/. Accessed: 2021 Jun 10.
- Pan XW, Xu D, Zhang H, et al. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med. 2020;46(6):1114–1116. doi: 10.1007/s00134-020-06026-1
- Pavlov VN, Tarasenko AI, Papoyan AO, et al. Acute kidney injury in the pathogenesis of coronavirus infection. Urology. 2021;2: 116–119. (In Russ.) doi: 10.18565/urology.2021.2.116-119
- Kulchavenya EV, Kholtobin DP, Neimark AI. The work of the urology department during the COVID-19 epidemic. Urology report (St. Petersburg.) 2020;10(4):301–307. doi: 10.17816/uroved52792 (In Russ.)
- Nechaeva OB. The state and prospects of the anti-tuberculosis service in Russia during the period of COVID-19. Tuberculosis and lung diseases. 2020;98(12):7–19. doi: 10.21292/2075-1230-2020-98-12-7-19 (In Russ.)
- Kulchavenya EV. Extrapulmonary tuberculosis during the COVID-19 pandemic: features of detection and course. Consilium Medicum. 2021;23(7):585–589. doi: 10.26442/20751753.2021.7.201134 (In Russ.)
- Desouky E. BCG versus COVID-19: impact on urology. World J Urol. 2021;39(3):823–827. doi: 10.1007/s00345-020-03251-7
- Hegarty PK, Kamat AM, Dinardo A, Zafirakis H. BCG vaccination may be protective against Covid-19. Available from: https://www.researchgate.net/publication/340224580_BCG_vaccination_may_be_protective_agains
- Mahase E. Covid-19: what treatments are being investigated? BMJ. 2020;368: m1252. doi: 10.1136/bmj.m1252
- Urotoday.com [Internet]. Beyond Bladder Cancer: Bacillus Calmette-Guérin (BCG) Vaccination Revisited as a Strategy to Reduce COVID-19 Related Adverse Events in High Risk Health Care Workers and the Elderly. Available from: https://www.urotoday.com/library-resources/bladder-cancer/120412-beyond-bladder-cancer-bacillus-calmette-guerin-bcg-vaccination-revisited-as-a-strategy-to-reduce-covid-19-hospitalization-in-the-elderly.html
- Oliver F, Nikhil V, Paula A, et al. Immunotherapy for bladder cancer. Res Rep Urol. 2015;7:65–79. doi: 10.2147/RRU.S63447
- Buffen K, Oosting M, Quintin J, Ng A, et al. Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer. PLoS Pathog. 2014;10(10):e1004485. doi: 10.1371/journal.ppat.1004485
- American Urology Assotiation. Available from: https://www.auane t.org/about -us/bcg-short age-info. Accessed: 2022 Feb 6.
- Noguera-Ortega E, Rabanal RM, Gómez-Mora E, et al. Intravesical Mycobacterium brumae triggers both local and systemic immunotherapeutic responses against bladder cancer in mice. Sci Rep. 2018;8(1):15102. doi: 10.1038/s41598-018-33253-w